Do you want to read an article? Please log in or register.
Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD
Related content
RECOMMENDED
Pulmonary FibrosisRespiratory Tract Infection
The role of viral and bacterial infections in the pathogenesis of IPF: a systematic review and meta-analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res
Mostafaei S, Sayad B, Azar MEF, Doroudian M, Hadifar S, Behrouzi A, Riahi P, Hussen BM, Bayat B, Nahand JS, Moghoofei M
doi: 10.1186/s12931-021-01650-x
RECOMMENDED
Respiratory Tract Infection
Systemic biomarkers in respiratory tract infections
Rev Med Suisse.
Balmpouzis Z, Diamanti E, Kritikos A, Guery B, Nicod LP
Microorganisms Causing Community-Acquired Acute Bronchitis: The Role of Bacterial Infection
PLoS One.
Park JY, Park S, Lee SH, Lee MG, Park YB, Oh KC, Lee JM, Kim DI, Seo KH, Shin KC, Yoo KH, Ko Y, Jang SH, Jung KS, Hwang YI
doi: 10.1371/
COPD
Feasibility of deriving a novel imaging biomarker based on patient-specific lung elasticity for characterizing the degree of COPD in lung SBRT patients
Br J Radiol. 2
Hasse K, Neylon J, Min Y, O'Connell D, Lee P, Low DA, Santhanam AP
doi: 10.1259/bjr.20180296.
RECOMMENDED
COPD
COPD Biomarkers and their Interpretation
Am J Respir Crit Care Med.
Stockley RA, Halpin DMG, Celli BR, Singh D
doi: 10.1164/rccm.201810-1860SO.
Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease
PLoS One.
La Manna MP, Orlando V, Li Donni P, Sireci G, Di Carlo P, Cascio A, Dieli F, Caccamo N
doi: 10.1371/
RECOMMENDED
COPD
Time-course of upper respiratory tract viral infection and COPD exacerbation
Eur Respir J.
Stolz D, Papakonstantinou E, Grize L, Schilter D, Strobel W, Louis R, Schindler C, Hirsch HH, Tamm M
doi: 10.1183/13993003.
RECOMMENDED
PneumoniaRespiratory Tract Infection
Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
J Infect Dis.
2019 Apr
Talbot GH, Das A, Cush S, Dane A, Wible M, Echols R, Torres A, Cammarata S, Rex JH, Powers JH, Fleming T, Loutit J, Hoffmann S; Foundation for the National Institutes of Health Biomarkers Consortium HABP/VABP Project Team
doi: 10.1093/infdis/jiy578.
RECOMMENDED
Bronchi
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
Lancet Respir Med.
Haworth CS, Bilton D, Chalmers JD, Davis AM, Froehlich J, Gonda I, Thompson B, Wanner A, O'Donnell AE
doi: 10.1016/S2213-2600(18)30427-2.